• Member News

How are companies across the Bruntwood SciTech network improving access to better healthcare, medicines and treatments?

The Bruntwood SciTech network is home to some of the UK’s most pioneering science companies, from small medtech startups and scaleups, all the way through to global life science companies that are uncovering world-leading discoveries, creating new medicines and shaping the future of our healthcare. So who are some of the UK’s most innovative life science businesses at the forefront of helping to create a fairer and healthier world?

The Babraham Research Campus sets out its vision and ambition for its future

Cambridge, 12th May 2021: The Babraham Research Campus’ vision is to be one of the best places in the world for discovery bioscience research and innovation; a leading sustainable ecosystem to start, nurture, scale and grow bioscience business.

Magdalen College seeks Strategic Partner to accelerate development of The Oxford Science Park

Oxford, UK, May 10 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, has announced that it is seeking a strategic partner with which to accelerate development of the Park.

Abingworth raises $582 million for new Clinical Co-Development Fund – ACCD 2

New oversubscribed global fund to invest in late-stage clinical programmes with pharma/biotech partners Abingworth has closed on over $1 billion in 2021 in two new funds

Applications invited for Accelerate@Babraham life science start-up competition

Five months, five companies: Life-changing ideas, game-changing support. Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.


Leading pharmaceutical contract development and manufacturing organisation (CDMO) Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company won its award for International Trade.

Discovery Park & National Horizons Centre agree partnership

A partnership between the National Horizons Centre and Discovery Park, the Life Sciences Opportunity Zone for ambitious companies, is promising to bring opportunities to both organisations.

Exploristics announces global launch of the Spring 2021 release of its clinical trial design platform, KerusCloud.

Exploristics is pleased to announce the global launch of the Spring 2021 release of its ground-breaking clinical trial design platform, KerusCloud.

Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella

Key milestone achieved in project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella.

Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax®-Enabled Pandemic Influenza Vaccine

• Innovative needle-free injectable unit solid-dose presentation of recombinant H7N9 pandemic flu vaccine, created using Enesi’s ImplaVax® technology, generated immune responses comparable with liquid vaccine and demonstrated excellent thermal stability at temperatures up to 40°C for six months.